Back to accessibility links


The Reducing Unwarranted Clinical Variation Taskforce was convened in 2012.

Unwarranted clinical variation cannot be explained by the condition or the preference of the patient; it is variation that can only be explained by differences in health system performance.

Left unchecked it has the potential to reduce safety, quality, patient experience, performance effectiveness and efficiency outcomes.


The purpose of the Taskforce (in consultation with clinicians, managers and other stakeholders) is to oversee the development of:

  • a system-wide Strategy to Reduce Unwarranted Clinical Variation (UCV)
  • an approach for identifying, analysing and acting on UCV
  • reports to government and other stakeholders on progress and outcomes
  • strategies to engage and represent different stakeholders involved in addressing UCV
  • strategies for the provision of consistent key messaging  and targeted communication
  • clear roles and accountabilities for all parts of the health system in addressing UCV

Reducing UCV Taskforce Current Projects

  • Mortality:  Stroke, Hip Fracture, Low Volume cancer surgeries (oesphagectomies and pancreatectomies).
  • Length of Stay (LOS) & Cost: Prostate surgery, Childbirth, Selected surgical groups areas (Lap Chole, Appendicectomy, Hysterectomy).
  • Scoping: "Appropriateness", "Low value care", Clinician identified areas (eg Colorectal Surgery).